Core Viewpoint - Harrow Health (HROW) has garnered investor interest, with a recent "Outperform" rating from William Blair, despite a notable decline in stock price [1][3]. Financial Performance - The Q4 2025 earnings call provided insights into Harrow's financial performance, highlighting achievements and challenges, as well as future outlook [2]. - Harrow Health's market capitalization is approximately $1.43 billion, indicating its size and market presence [4]. Stock Performance - HROW has seen a significant decrease of about 28%, with a drop of $14.99, and the stock price fluctuated between $38.56 and $44.68 during the day [3]. - Over the past year, the stock reached a high of $54.85 and a low of $20.85, reflecting volatility [3]. - The trading volume of 3,933,928 shares indicates active investor interest, which is important for understanding liquidity and growth potential [4].

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on SoundHound AI, Inc. (SOUN), and emphasizes the importance of using these recommendations in conjunction with other analytical tools for making investment decisions [1][5]. Group 1: Brokerage Recommendations - SoundHound AI has an average brokerage recommendation (ABR) of 1.67, indicating a position between Strong Buy and Buy, based on recommendations from nine brokerage firms [2]. - Out of the nine recommendations, six are classified as Strong Buy, accounting for 66.7% of the total recommendations [2]. - Despite the favorable ABR, relying solely on this information for investment decisions may not be advisable, as studies suggest brokerage recommendations often lack success in guiding investors towards stocks with significant price appreciation potential [5][11]. Group 2: Analyst Bias and Tools - Brokerage analysts tend to exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell recommendations [6][11]. - The Zacks Rank, a proprietary stock rating tool, is highlighted as a more reliable indicator of near-term price performance, as it is based on earnings estimate revisions rather than brokerage recommendations [8][12]. - The Zacks Rank is timely and reflects changes in earnings estimates quickly, unlike the ABR, which may not always be up-to-date [13]. Group 3: Current Earnings Estimates for SoundHound AI - The Zacks Consensus Estimate for SoundHound AI for the current year remains unchanged at -$0.13, indicating steady analyst views on the company's earnings prospects [14]. - The unchanged consensus estimate has resulted in a Zacks Rank of 3 (Hold) for SoundHound AI, suggesting a cautious approach despite the Buy-equivalent ABR [15].

Company Overview - Tyler Technologies, Inc. is based in Plano, Texas and provides integrated software and technology management solutions, with a market cap of $13.6 billion [1] Stock Performance - Over the past 52 weeks, Tyler Technologies has significantly underperformed the broader market, with shares declining 49%, while the S&P 500 Index has increased by 13% [2] - Year-to-date, the stock is down 30.8%, contrasting with a marginal rise in the S&P 500 [2] - The company has also lagged behind the State Street SPDR S&P Software & Services ETF, which decreased by 21.5% over the past 52 weeks [3] Financial Results - On February 11, Tyler Technologies reported weaker-than-expected Q4 results, leading to a 15.4% drop in shares the following trading session [5] - The adjusted EPS for Q4 was $2.64, falling short of the consensus estimate of $2.71, and revenue was $575.2 million, missing analyst expectations by 2.4% [5] Future Earnings Expectations - For fiscal 2026, analysts expect Tyler Technologies' EPS to grow by 13.2% year-over-year to $9.97 [6] - The company's earnings surprise history is mixed, having topped consensus estimates in three of the last four quarters [6] Analyst Ratings - Among the 22 analysts covering Tyler Technologies, the consensus rating is a "Strong Buy," with 16 "Strong Buy," one "Moderate Buy," and five "Hold" ratings [6] - The configuration has become more bullish, with 15 analysts suggesting a "Strong Buy" rating [7] - Peter Heckmann from D.A. Davidson maintained a "Buy" rating with a price target of $460, indicating a potential upside of 46.8% from current levels [7] - The mean price target is $459.65, suggesting a 46.7% potential upside, while the highest price target of $675 indicates a potential upside of 115.4% [7]

Core Insights - Everest Group, Ltd. (EG) is a Bermuda-based insurance company with a market capitalization of $14.4 billion, providing property, casualty, and specialty reinsurance and insurance solutions [1] Performance Overview - Over the past 52 weeks, EG has underperformed the broader market, gaining only 1.3% compared to the S&P 500 Index's increase of 11.7% [1] - Year-to-date, EG's stock performance is marginally up, aligning with the S&P 500 Index [1] - EG has outperformed the State Street SPDR S&P Insurance ETF (KIE), which declined 4.1% year-to-date [2] Financial Results - In Q4, EG reported a total revenue decline of 4.6% year-over-year to $4.4 billion, although this figure exceeded analyst expectations by 2.6% [5] - The company's net operating income per share was $13.26, a recovery from an operating loss of $18.39 per share in the previous year, but it slightly missed consensus estimates [5] Earnings Forecast - For fiscal 2026, analysts project EG's EPS to grow by 21.3% year-over-year to $54.01 [6] - The company's earnings surprise history shows it missed consensus estimates in three of the last four quarters, with one occasion of surpassing expectations [6] Analyst Ratings - Among 19 analysts covering EG, the consensus rating is a "Moderate Buy," consisting of five "Strong Buy," two "Moderate Buy," 11 "Hold," and one "Strong Sell" rating [6] - Bob Huang from Morgan Stanley maintained a "Hold" rating with a price target of $330, while the mean price target of $361.62 indicates a potential upside of 5.6% from current levels [8] - The highest price target of $430 suggests a potential upside of 25.6% from current levels [8]

Core Insights - Huntington Ingalls Industries, Inc. (HII) has a market capitalization of $17.4 billion and specializes in designing, building, overhauling, and repairing military ships [1] - Over the past 52 weeks, HII's stock has increased by 147.3%, significantly outperforming the S&P 500 Index, which rose by 11.7% during the same period [1] - Year-to-date, HII's stock is up 29.4%, while the S&P 500 has shown only a marginal increase [1] - HII has also outperformed the Invesco Aerospace & Defense ETF (PPA), which gained 54.9% over the past year [2] Financial Performance - In Q4, HII reported sales and service revenue of $3.5 billion and an EPS of $4.04, exceeding consensus estimates [3] - Compared to the same quarter last year, HII's revenue increased by 15.7%, and its EPS grew by 28.3% [3] - For fiscal 2026, analysts project HII's EPS to grow by 11.6% year-over-year to $17.18 [4] - HII has consistently surpassed consensus estimates in the last four quarters [4] Analyst Ratings - The consensus rating among 12 analysts covering HII is a "Moderate Buy," with five "Strong Buy" and seven "Hold" ratings [4] - Bank of America upgraded HII to "Neutral" and raised its price target to $400, indicating a potential upside of 5.3% from the current levels [7]

Core Insights - Waldencast PLC (NASDAQ: WALD) has received an average recommendation of "Moderate Buy" from six ratings firms, with one sell, one hold, and four buy recommendations. The average twelve-month price target is $4.4167 [2] Analyst Recommendations - Weiss Ratings reiterated a "sell (e+)" rating on Waldencast shares [3] - Jefferies Financial Group initiated coverage with a "buy" rating and a price target of $2.00 [3] - Canaccord Genuity Group lowered its price target from $5.00 to $4.00 while maintaining a "buy" rating [3] - Telsey Advisory Group downgraded the stock from "outperform" to "market perform" with a price objective of $3.00 [3] Institutional Holdings - UBS Group AG increased its holdings by 466.2% in Q3, owning 838,536 shares valued at $1.66 million after purchasing 690,441 shares [4][5] - Milestones Administradora de Recursos Ltda. raised its stake by 10.3% in Q3, owning 2,425,677 shares valued at $4.803 million after buying 225,677 shares [4][5] - Geode Capital Management LLC increased its holdings by 62.2% in Q2, owning 586,566 shares worth $1.437 million after purchasing 224,905 shares [4][5] - McAdam LLC raised its holdings by 174.6% in Q3, owning 63,014 shares worth $125,000 after buying 40,063 shares [4][5] - Squarepoint Ops LLC acquired a new position worth $78,000 in Q3 [4][5] - Institutional investors and hedge funds currently own 41.97% of the stock [4][5] Price Performance - Waldencast shares opened at $1.80, with a twelve-month low of $1.45 and a high of $3.54 [6] - The company has a current ratio of 1.53, a quick ratio of 0.67, and a debt-to-equity ratio of 0.32 [6] - The 50-day simple moving average is $1.80, and the 200-day simple moving average is $1.88 [6] Financial Performance - Waldencast reported an EPS of ($0.69) for the last quarter, with revenue of $66.14 million [7] - Analysts expect the company to post an EPS of -0.14 for the current year [7] Company Overview - Waldencast operates in the beauty and wellness sector, focusing on developing, acquiring, and scaling various brands [8] - The company offers products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands, as well as clean makeup products under the Milk Makeup brand [8][9] - Its products are sold to dermatologists, plastic surgeons, and other physicians, as well as through direct sales and distribution partners [9]

Core Viewpoint - Tesla's stock experienced a rise due to a new buy rating from Wall Street, but ultimately failed to maintain gains, ending a four-day winning streak as the market declined [1]. Group 1: Stock Performance - Tesla's stock was up 30% over the past 12 months leading into Thursday trading [1]. - The stock initially rose on Thursday but could not sustain the gains, resulting in a decline [1]. Group 2: Market Context - The overall market experienced a sell-off, which contributed to Tesla's inability to maintain its stock gains [1].

Core Insights - The Allstate Corporation (ALL) has a market capitalization of $53.6 billion and has underperformed the broader market over the past 52 weeks, with a share price increase of 9.1% compared to the S&P 500 Index's 14.4% rise [1] - Year-to-date, ALL's stock is down slightly, while the S&P 500 has returned 1.4% [1] Performance Comparison - ALL has outperformed the State Street SPDR S&P Insurance ETF (KIE), which increased by 1.2% over the past 52 weeks and declined by 3.7% year-to-date [2] Financial Results - In Q4, ALL reported mixed results with total revenue rising 5.1% year-over-year to $17.3 billion, although it missed consensus estimates [4] - The adjusted EPS for the quarter grew by 86.6% year-over-year to $14.31, exceeding analyst expectations of $9.82 [4] Future Earnings Expectations - For fiscal 2026, analysts project a decline in ALL's EPS by 28.7% year-over-year to $24.85 [5] - The company has a strong earnings surprise history, having exceeded consensus estimates in the last four quarters [5] Analyst Ratings - Among 24 analysts covering ALL, the consensus rating is a "Moderate Buy," with 12 "Strong Buy," one "Moderate Buy," nine "Hold," and two "Strong Sell" ratings [5] - The mean price target is $242.45, indicating an 18.5% premium to the current price, while the highest price target of $281 suggests a potential upside of 37.3% [7]

Core Insights - Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $202.8 billion and provides a range of life sciences solutions and services [1] - Over the past 52 weeks, TMO shares have declined by 2.4%, underperforming the S&P 500 Index, which gained 14.4% [1] - Year-to-date, TMO stock is down 6.8%, while the S&P 500 has risen by 1.4% [1] Performance Comparison - TMO has also underperformed the State Street Health Care Select Sector SPDR ETF (XLV), which increased by 6.2% over the past 52 weeks [2] - On January 29, TMO shares fell by 2.6% despite reporting better-than-expected Q4 results, with revenue of $12.2 billion and adjusted EPS of $6.57, both exceeding analyst estimates [4] - The company's revenue grew by 7.2% year-over-year, while adjusted EPS increased by 7.7% [4] Financial Outlook - Analysts project TMO's EPS to grow by 7.8% year-over-year to $24.65 for fiscal 2026 [5] - TMO has a strong earnings surprise history, exceeding consensus estimates in the last four quarters [5] - Among 23 analysts covering TMO, the consensus rating is a "Strong Buy," with 18 "Strong Buy," 2 "Moderate Buy," and 3 "Hold" ratings [5] Analyst Ratings and Price Targets - The configuration of analyst ratings has become more bullish, with 16 analysts suggesting a "Strong Buy" rating [7] - JPMorgan Chase & Co. maintained a "Buy" rating on TMO with a price target of $710, indicating a potential upside of 31.5% [7] - The mean price target is $662.95, representing a 22.8% premium, while the highest price target of $750 suggests a potential upside of 38.9% [7]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence in investing [1] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum methodologies, helping investors identify stocks likely to outperform the market in the next 30 days [2] - Each stock receives a rating from A to F based on its characteristics, with A indicating the highest potential for outperformance [3] Value Score - The Value Style Score identifies attractive and discounted stocks using ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, appealing to value investors [3] Growth Score - The Growth Style Score focuses on a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow to find stocks with sustainable growth [4] Momentum Score - The Momentum Style Score helps investors capitalize on price trends by analyzing factors like one-week price changes and monthly earnings estimate changes [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive indicator that evaluates stocks based on value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to assist in building a successful portfolio, with 1 (Strong Buy) stocks achieving an average annual return of +23.83% since 1988, significantly outperforming the S&P 500 [7] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to select the best options [8] Stock to Watch: Corning (GLW) - Corning Incorporated, a company with a history in glass technology, is currently rated 3 (Hold) with a VGM Score of B [11] - Corning is a potential growth investment, with a Growth Style Score of B and a forecasted year-over-year earnings growth of 21.8% for the current fiscal year [12] - Recent analyst revisions have increased the earnings estimate for fiscal 2026 by $0.07 to $3.07 per share, with an average earnings surprise of +4.4%, making it a strong candidate for investors [12]